Khalilpour Akbar, Osman Sabariah, Yunus Muhammad Hafiznur, Santhanam Amutha, Vellasamy Nagarajan, Noordin Rahmah
Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800, Minden, Penang, Malaysia.
BMC Res Notes. 2014 Nov 18;7:809. doi: 10.1186/1756-0500-7-809.
Helicobacter pylori is a human pathogen and during the process of infection, antigens from the bacterium elicit strong host humoral immune responses. In our previous report, native H. pylori UreG protein showed good reactivity with sera from H. pylori patients. This study was aimed at producing the recombinant form of the protein (rUreG) and determining its seroreactivities.
The coding sequence of H. pylori UreG was cloned and the recombinant protein expressed and purified by affinity chromatography using nickel nitrilotriacetic acid (Ni-NTA) resin. The antigenicity of rUreG to detect H. pylori specific antibodies was determined by western blot, using HRP-conjugated anti-human IgG and IgA antibodies as probes. A total of 70 sera, comprising 30 positive and 40 control serum samples, were used. The positive sera were from culture-positive H. pylori-infected patients with duodenal ulcers, gastric ulcers, or gastritis. The control sera comprised three types of samples without detectable H. pylori antibodies, i.e. healthy individuals (with no history of gastric disorders) (n = 10); patients who attended an endoscopy clinic (because of gastrointestinal complaints) but were H. pylori culture negative (n = 20); and people with other diseases (n = 10). Additionally, hyperimmune mice serum against rUreG was raised and tested with the native and recombinant UreG protein.
The ureG gene fragment was successfully cloned and expressed in both soluble and insoluble forms. Western blots on rUreG protein showed 70% (21/30) and 60% (18/30) reactivity with patients' sera when probed with HRP-conjugated anti-human IgG and IgA antibodies, respectively; and the combination of the IgG and IgA western blots showed reactivity of 83.3% (25/30). By comparison, 97.5% and 92.5% of the control sera showed no reactivity when probed with HRP-conjugated anti-human IgG and IgA antibodies, respectively. Both the H. pylori lysate antigen and rUreG protein displayed a distinctive band at the expected molecular weight when probed with the hyperimmune mice serum.
The rUreG protein was successfully cloned and expressed and showed good reactivity with H. pylori culture-positive patients' sera and no reactivity with most control sera. Thus, the diagnostic potential of this recombinant protein merits further investigation.
幽门螺杆菌是一种人类病原体,在感染过程中,该细菌的抗原会引发强烈的宿主体液免疫反应。在我们之前的报告中,天然幽门螺杆菌UreG蛋白与幽门螺杆菌患者的血清显示出良好的反应性。本研究旨在制备该蛋白的重组形式(rUreG)并确定其血清反应性。
克隆幽门螺杆菌UreG的编码序列,使用镍三乙酸(Ni-NTA)树脂通过亲和层析表达并纯化重组蛋白。通过蛋白质印迹法,使用辣根过氧化物酶(HRP)偶联的抗人IgG和IgA抗体作为探针,测定rUreG检测幽门螺杆菌特异性抗体的抗原性。总共使用了70份血清,包括30份阳性和40份对照血清样本。阳性血清来自十二指肠溃疡、胃溃疡或胃炎的幽门螺杆菌培养阳性感染患者。对照血清包括三种未检测到幽门螺杆菌抗体的样本,即健康个体(无胃部疾病史)(n = 10);因胃肠道不适到内镜门诊就诊但幽门螺杆菌培养阴性的患者(n = 20);以及患有其他疾病的人(n = 10)。此外,制备了抗rUreG的超免疫小鼠血清,并用天然和重组UreG蛋白进行检测。
ureG基因片段成功克隆并以可溶性和不溶性形式表达。用HRP偶联的抗人IgG和IgA抗体检测时,rUreG蛋白的蛋白质印迹分别显示与患者血清的反应性为70%(21/30)和60%(18/30);IgG和IgA蛋白质印迹的组合显示反应性为83.3%(25/30)。相比之下, 用HRP偶联的抗人IgG和IgA抗体检测时,分别有97.5%和92.5%的对照血清无反应性。用超免疫小鼠血清检测时,幽门螺杆菌裂解物抗原和rUreG蛋白在预期分子量处均显示出一条独特的条带。
rUreG蛋白成功克隆并表达,与幽门螺杆菌培养阳性患者的血清显示出良好的反应性,与大多数对照血清无反应性。因此,这种重组蛋白的诊断潜力值得进一步研究。